v3.24.1.u1
Interim Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities    
Net loss for the year $ (18,541) $ (713)
Items not affecting cash:    
Stock based compensation 324 253
Net realizable value adjustments 1,139 2,875
Amortization of mineral properties (22) 313
Depreciation of capital assets 603 473
Accretion expense 121 122
Amortization of deferred loan costs 33 11
Provision for reclamation (6) 0
Mark to market loss (gain) (2,756) 1,867
Unrealized foreign exchange lgain (12) (336)
Changes in non-cash working capital:    
Lease receivable 13 0
Inventory 3,266 (753)
Prepaid expenses (131) (170)
Accounts payable and accrued liabilities 2,612 613
Cash provided by used in operating activities (14,377) 2,327
Investing activities    
Purchase of capital assets (843) (665)
Cash provided by used in investing activities (843) (665)
Financing activities    
Issuance of common shares for cash 4,227 46,637
Share issue costs (106) (2,914)
Proceeds from exercise of warrants and stock options 11,202 298
Repayment of debt (5,767) (1,324)
Cash provided by used in financing activities 9,556 42,697
Effects of foreign exchange rate changes on cash (48) 0
Increase (decrease) in cash, cash equivalents, and restricted cash (5,712) 44,359
Beginning cash, cash equivalents, and restricted cash 68,249 41,140
Ending cash, cash equivalents, and restricted cash $ 62,537 $ 85,499

Source